• Prostate Cancer: The Paradox of Choice
  • FDA Approves Trulicity Type 2 Diabetes Treatment, But Requires Further Study
  • Psoriasis and Psoriatic Arthritis Patient Care: What Pharmacists Should Know
  • Alopecia: Hormonal and Hereditary Factors
  • Can You Read These Rxs?

Breaking News

Null Findings on Selenium Supplements for Cataract Prevention
Selenium and vitamin E supplementation will not prevent cataracts in men, a new study suggests.
Combining 2 classes of COPD medications leads to better outcomes for older adults with comorbid asthma.
A first-of-its-kind blood test delivers an objective diagnosis of major depressive disorder, as well as predicts which adult patients will benefit from cognitive behavioral therapy.
The severe respiratory virus that is hospitalizing children across the United States has now been confirmed in 17 states.
The FDA today approved dulaglutide (Trulicity), a once-weekly injectable therapy indicated to improve blood sugar control in adults with type 2 diabetes.
Just a dozen drug ingredients are the culprits behind nearly half of all emergency hospitalizations for unsupervised prescription drug ingestions among young children.
Pragma acquired Moxatag from Shionogi Inc in March 2014 and has been working to make the product available in time for the upcoming cold and flu season.

From the Issue

Previous TabNext Tab
Strategic Alliance Partners
Latest Issues